Department Circular 2021-0088: Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav Preparations

Please be informed of the following adjustments in the price of Government-Mediated Access Price (GMAP) medicines, as notified by GlaxoSmithKline, during the meeting of the Advisory Council for the Implementation of the Republic Act No. 9502 (Universally Accessible Cheaper and Quality Medicines Act of 2008) held 08 March 2021... read more>>>

PDF icon Department Circular No. 2021-008895.9 KB